What Are Reimbursable Out-Of-Pocket Medical Costs?

The landscape of American healthcare in 2026 continues to be defined by a widening gap between medical necessity and financial accessibility. As inflationary pressures persist, the burden of out-of-pocket medical expenses has reached a critical threshold for millions of households. According to recent data from KFF, the consequences of these rising costs are stark: approximately 75% of uninsured adults in the United States reported skipping or postponing essential medical care in 2025 due to cost concerns. Even among the insured, the struggle to manage deductibles, copayments, and non-covered services remains a primary driver of financial instability.

In response to this growing crisis, a significant shift is occurring within the corporate sector. Employers are increasingly moving away from traditional, one-size-fits-all group health plans in favor of more flexible, tax-advantaged reimbursement models. By understanding the intricacies of reimbursable medical expenses and utilizing tools such as Health Reimbursement Arrangements (HRAs), organizations are attempting to ease the financial burden on their workforce while maintaining a competitive edge in a labor market that prioritizes health benefits above almost all other perks.

The Growing Reality of Out-of-Pocket Medical Costs

Out-of-pocket costs are defined as the portion of medical expenses that health insurance does not cover. These costs must be paid directly by the individual before or alongside the insurer’s contributions. While health insurance is designed to provide a safety net, the reality for many is that the net has become increasingly porous.

Current data suggests that roughly half of all U.S. adults find it difficult to afford healthcare. About 30% of households reported significant trouble paying medical bills within the last 12 months. These expenses typically fall into several categories:

• Deductibles: The fixed amount an individual must pay for covered healthcare services before their insurance plan begins to pay.
• Copayments: A fixed amount paid by the patient for a covered healthcare service after the deductible has been met.
• Coinsurance: The patient’s share of the costs of a covered healthcare service, calculated as a percentage of the allowed amount for the service.
• Non-covered Services: Items or services that an insurance plan does not include in its benefits package, such as certain elective procedures or out-of-network care.

The financial ceiling for these expenses continues to rise. In 2026, the maximum out-of-pocket limit for an individual policy is set at $10,600, while family policies can reach a staggering $21,200. These limits generally apply only to in-network care; when individuals are forced to seek out-of-network specialists or emergency services, the financial exposure can be virtually unlimited.

A Chronology of Health Reimbursement Evolution

The transition toward the current reimbursement-centric model of employee benefits did not happen overnight. It is the result of over a decade of regulatory changes and shifting economic priorities.

1. 2010 – The Affordable Care Act (ACA): The ACA established the framework for modern health insurance, introducing mandates for coverage and defining essential health benefits. However, it also led to a rise in high-deductible health plans (HDHPs) as employers sought to manage rising premiums.
2. 2016 – The 21st Century Cures Act: This bipartisan legislation introduced the Qualified Small Employer Health Reimbursement Arrangement (QSEHRA). For the first time, small businesses (those with fewer than 50 full-time employees) could reimburse staff for individual insurance premiums and medical expenses tax-free without offering a group plan.
3. 2020 – The Expansion of HRAs: New federal regulations went into effect, creating the Individual Coverage Health Reimbursement Arrangement (ICHRA). This allowed employers of all sizes to offer a defined contribution for employees to purchase their own coverage on the open market, further decoupling health benefits from specific corporate group plans.
4. 2024-2026 – Post-Pandemic Economic Adjustment: Following several years of high inflation, the cost of medical services and prescription drugs spiked. This period saw a record number of employers adopting "defined contribution" models to provide employees with the liquidity needed to cover rising out-of-pocket costs.

The Strategic Utility of IRS Publication 502

Central to the administration of medical reimbursements is IRS Publication 502. This document outlines more than 200 types of medical and dental expenses that qualify for tax-free reimbursement. For employees managing chronic conditions—such as diabetes, heart disease, or autoimmune disorders—the ability to use pre-tax dollars for these expenses is a vital financial lifeline.

Eligible expenses under IRS Section 213(d) include:

• Prescription Drugs: Essential medications required to treat diagnosed conditions.
• Professional Services: Payments to doctors, dentists, surgeons, chiropractors, and mental health professionals.
• Diagnostic Devices: Equipment such as blood sugar test kits or heart rate monitors.
• Specialized Care: Inpatient hospital care, residential nursing care, and physical therapy.
• Ancillary Costs: In some cases, transportation costs primarily for and essential to medical care can be reimbursed.

By leveraging the broad definitions in Publication 502, employers can offer a benefits package that is far more inclusive than a standard insurance formulary. This flexibility allows employees to tailor their healthcare spending to their specific needs, whether that involves mental health counseling, specialized dental surgery, or advanced vision care.

Comparing Employer-Funded Solutions: HRAs vs. Stipends

Organizations looking to support their employees’ out-of-pocket costs generally choose between two primary mechanisms: the HRA and the health stipend. Each has distinct regulatory and fiscal implications.

Health Reimbursement Arrangements (HRAs)
HRAs are employer-funded, tax-advantaged accounts. They are not "accounts" in the sense of a bank deposit; rather, they are a commitment to reimburse.

• Tax Efficiency: All reimbursements are 100% tax-free for the employer (no payroll taxes) and 100% tax-free for the employee (no income tax).
• Control: Employers can set a monthly or annual cap on reimbursements, ensuring predictable benefit costs.
• Compliance: HRAs must meet specific IRS and ACA requirements, often requiring a third-party administrator to ensure proper documentation and privacy.

The three most common HRAs in the 2026 market include:

1. ICHRA: The most flexible option, allowing employers to scale contributions based on employee classes (e.g., full-time vs. part-time).
2. QSEHRA: Designed specifically for small businesses, offering a simplified way to provide health benefits without the complexity of group insurance.
3. Integrated HRA: Used alongside a traditional group health plan to help employees cover the high deductibles associated with those plans.

Health Stipends
For employers seeking maximum simplicity, a health stipend offers an alternative. This is a fixed sum added to an employee’s paycheck to help with medical costs.

• Pros: Minimal administrative overhead and no requirement for employees to submit receipts.
• Cons: Stipends are considered taxable income. Both the employer and the employee must pay taxes on these funds, reducing the "real" value of the benefit by 20% to 40% depending on the tax bracket. Furthermore, stipends do not satisfy the ACA employer mandate for large organizations.

Industry Perspectives and Economic Implications

Industry analysts suggest that the shift toward HRAs reflects a broader "retailization" of healthcare. Much like the transition from defined-benefit pensions to 401(k) plans, the move to HRAs gives employees more agency while providing employers with cost certainty.

"The traditional group plan model is struggling to keep pace with the diversity of employee needs," says a benefits consultant specializing in mid-market firms. "In 2026, a 25-year-old remote worker in Colorado and a 55-year-old office manager in New York have fundamentally different healthcare requirements. An HRA allows the employer to support both individuals equally and efficiently."

From a macro-economic perspective, the rise of reimbursement models may also impact healthcare pricing. When employees become "shoppers" of healthcare—using their HRA funds to choose providers and services—there is an increased pressure on providers to offer transparent pricing and better value. However, critics argue that this shift places a greater cognitive and administrative burden on employees, who must now navigate the complexities of insurance markets and IRS regulations on their own.

Conclusion: The Path Forward for 2026 and Beyond

As out-of-pocket limits reach historic highs, the role of the employer in the American healthcare system is being redefined. No longer just a purchaser of group policies, the modern employer is increasingly a facilitator of financial health. By utilizing HRAs, companies can mitigate the risk of their employees skipping essential care, thereby maintaining a healthier, more productive workforce.

For organizations, the choice between an HRA and a stipend—or between a group plan and an ICHRA—is a strategic one. It requires a balance of tax efficiency, administrative capacity, and a deep understanding of the workforce’s demographic needs. As the 2026 fiscal year progresses, the data suggests that those who embrace the flexibility of reimbursement-based benefits will be best positioned to weather the ongoing challenges of healthcare inflation and employee retention.